Recipharm Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Private

  • Employees
  • 5,900

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 4

  • Investments
  • 38

Recipharm General Information

Description

Operator of pharmaceutical contract development and manufacturing organization (CDMO) intended for pharmaceutical and biotech companies. The company's services cover the entire life cycle of a pharmaceutical product from drug substance through to commercial manufacturing, thereby enabling clients to get products to market in a timely and cost-efficient way.

Contact Information

Website
www.recipharm.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Box 603
  • 101 32 Stockholm
  • Sweden
+46
Primary Industry
BPO/Outsource Services
Other Industries
Pharmaceuticals
Corporate Office
  • Box 603
  • 101 32 Stockholm
  • Sweden
+46

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Recipharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Recipharm‘s full profile, request access.

Request a free trial

Recipharm Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of pharmaceutical contract development and manufacturing organization (CDMO) intended for pharmaceutical and bi
BPO/Outsource Services
Stockholm, Sweden
5,900 As of 2024

Munich, Germany
 

Clearwater, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Recipharm Competitors (33)

One of Recipharm’s 33 competitors is Adragos Pharma, a Private Equity-Backed company based in Munich, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adragos Pharma Private Equity-Backed Munich, Germany
CoreRx Private Equity-Backed Clearwater, FL
PNP Pharmaceuticals Private Equity-Backed Burnaby, Canada
Catalent Private Equity-Backed Somerset, NJ
Pharmaceutics International Private Equity-Backed Hunt Valley, MD
You’re viewing 5 of 33 competitors. Get the full list »

Recipharm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Recipharm Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Recipharm‘s full profile, request access.

Request a free trial

Recipharm Investments & Acquisitions (38)

Recipharm’s most recent deal was a Early Stage VC with NewBiologix for . The deal was made on 11-May-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NewBiologix 11-May-2023 Early Stage VC Drug Discovery
Arranta Bio 08-Apr-2022 Buyout/LBO BPO/Outsource Services
Vibalogics 08-Apr-2022 Buyout/LBO Biotechnology
GenIBET Biopharmaceuticals 01-Feb-2022 Buyout/LBO Other Pharmaceuticals and Biotechnology
MARBIO 03-Oct-2021 Joint Venture Pharmaceuticals
You’re viewing 5 of 38 investments and acquisitions. Get the full list »

Recipharm Exits (7)

Recipharm’s most recent exit was on 24-Feb-2020 from Cinclus Pharma. The exit was categorized as with 5 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Cinclus Pharma 24-Feb-2020 Completed
  • 5 buyers
Cinclus Pharma 24-Apr-2019 Completed
  • 4 buyers
Xspray Pharma 02-Oct-2015 Completed
  • 2 buyers
Xspray Pharma 29-Sep-2015 Completed
  • 2 buyers
Palette Life Sciences 09-Jul-2015 Later Stage VC Completed
  • 3 buyers
You’re viewing 5 of 7 exits. Get the full list »

Affiliates

Subsidiaries (6)

Name Industry Location Year Founded
Resyca Munich, Germany 2020
Inject Pharma Sweden Sundsvall, Sweden 2015
Recipharm Pharmaceutical Development Solna, Sweden 2010
Recipharm Ot Chemistry Uppsala, Sweden 2008
AstraZeneca (A Sterile Manufacturing Factory in Monts) Monts, France 1994
You’re viewing 5 of 6 affiliates. Get the full list.  »

Recipharm FAQs

  • When was Recipharm founded?

    Recipharm was founded in 1995.

  • Where is Recipharm headquartered?

    Recipharm is headquartered in Stockholm, Sweden.

  • What is the size of Recipharm?

    Recipharm has 5,900 total employees.

  • What industry is Recipharm in?

    Recipharm’s primary industry is BPO/Outsource Services.

  • Is Recipharm a private or public company?

    Recipharm is a Private company.

  • What is Recipharm’s current revenue?

    The current revenue for Recipharm is .

  • How much funding has Recipharm raised over time?

    Recipharm has raised $149M.

  • Who are Recipharm’s investors?

    Ampersand (Private Equity), Ardian, and EQT have invested in Recipharm.

  • Who are Recipharm’s competitors?

    Adragos Pharma, CoreRx, PNP Pharmaceuticals, Catalent, and Pharmaceutics International are some of the 33 competitors of Recipharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »